世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の静脈内輸液バッグ市場 2018-2022年

Global Intravenous Fluid Bags Market 2018-2022

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年3月US$2,500
シングルユーザライセンス
113

サマリー

このレポートは世界の静脈内輸液バッグ市場を調査したTechNavioの調査報告書です。

Report Details

About Intravenous Fluid Bags
Intravenous fluids are used to store intravenous solutions for administering nutrition and medication intravenously for correcting electrolyte imbalance in patients.

Technavio’s analysts forecast the global intravenous fluid bags market to grow at a CAGR of 5.56% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous fluid bags market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of intravenous fluid bags.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Intravenous Fluid Bags Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- B. Braun Melsungen
- Baxter International
- Fresenius
- JW Life Science
- Pfizer (Hospira)
- Sippex IV bag


Market driver
- Growing demand for intravenous therapy due to increased prevalence of chronic diseases
- For a full, detailed list, view our report

Market challenge
- Concerns related to plastic intravenous bags
- For a full, detailed list, view our report

Market trend
- Continuous product innovation
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?


You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
- Segmentation by end-user
- Comparison by end-user
- Hospital
- Home healthcare
- Others
- Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas
- EMEA
- APAC
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Continuous product innovation
- Increase in demand from homecare
- Use in iron and vitamin infusions
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- B. Braun Melsungen
- Baxter International
- Fresenius
- JW Life Science
- Pfizer (Hospira)
- Sippex IV bag
- Other prominent vendors
PART 15: APPENDIX
- List of abbreviations
- Exhibit 01: Parent market
- Exhibit 02: Global medical specialty bags market
- Exhibit 03: Market characteristics
- Exhibit 04: Market segments
- Exhibit 05: Market definition - Inclusions and exclusions checklist
- Exhibit 06: Market size 2016
- Exhibit 07: Validation techniques employed for market sizing 2016
- Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
- Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
- Exhibit 10: Five forces analysis 2017
- Exhibit 11: Five forces analysis 2022
- Exhibit 12: Bargaining power of buyers
- Exhibit 13: Bargaining power of suppliers
- Exhibit 14: Threat of new entrants
- Exhibit 15: Threat of substitutes
- Exhibit 16: Threat of rivalry
- Exhibit 17: Market condition - Five forces
- Exhibit 18: Market condition - Five forces 2017
- Exhibit 19: Customer landscape
- Exhibit 20: End-user - Market share 2017-2022 (%)
- Exhibit 21: Comparison by end-user
- Exhibit 22: Hospitals - Market size and forecast 2017-2022 ($ mn)
- Exhibit 23: Hospitals - Year-over-year growth 2018-2022 (%)
- Exhibit 24: Countries with the most number of hospitals (2017)
- Exhibit 25: Home healthcare - Market size and forecast 2017-2022 ($ mn)
- Exhibit 26: Home healthcare - Year-over-year growth 2018-2022 (%)
- Exhibit 27: Others - Market size and forecast 2017-2022 ($ mn)
- Exhibit 28: Others - Year-over-year growth 2018-2021 (%)
- Exhibit 29: Market opportunity by end-user
- Exhibit 30: Global - Market share by geography 2017-2022 (%)
- Exhibit 31: Regional comparison
- Exhibit 32: Americas - Market size and forecast 2017-2022 ($ mn)
- Exhibit 33: Rise in population aged 65 and above in US (% of total)
- Exhibit 34: Americas - Year-over-year growth 2018-2022 (%)
- Exhibit 35: Top three countries in Americas
- Exhibit 36: EMEA - Market size and forecast 2017-2022 ($ mn)
- Exhibit 37: Healthcare expenditure per capita in Germany and UK 2012-2104 ($ mn)
- Exhibit 38: EMEA - Year-over-year growth 2018-2022 (%)
- Exhibit 39: Top three countries in EMEA
- Exhibit 40: APAC - Market size and forecast 2017-2022 ($ mn)
- Exhibit 41: APAC - Year-over-year growth 2018-2022 (%)
- Exhibit 42: Top three countries in APAC
- Exhibit 43: Market opportunity
- Exhibit 44: Rise in population aged 65 years and above (% of total)
- Exhibit 45: R&D funding for three diseases 2013-2016 ($ millions)
- Exhibit 46: Vendor landscape
- Exhibit 47: Landscape disruption
- Exhibit 48: Vendors covered
- Exhibit 49: Vendor classification
- Exhibit 50: Market positioning of vendors
- Exhibit 51: B. Braun Melsungen - Overview
- Exhibit 52: B. Braun Melsungen - Business segments
- Exhibit 53: B. Braun Melsungen - Organizational developments
- Exhibit 55: B. Braun Melsungen - Geographic focus
- Exhibit 56: B. Braun Melsungen - Segment focus
- Exhibit 57: B. Braun Melsungen - Key offerings
- Exhibit 58: Baxter International overview
- Exhibit 59: Baxter International - Business segments
- Exhibit 60: Baxter International - Organizational developments
- Exhibit 61: Baxter International - Geographic focus
- Exhibit 62: Baxter International - Segment focus
- Exhibit 63: Baxter - Key offerings
- Exhibit 64: Fresenius overview
- Exhibit 65: Fresenius - Business segments
- Exhibit 66: Fresenius - Organizational developments
- Exhibit 67: Fresenius - Geographic focus
- Exhibit 68: Fresenius - Segment focus
- Exhibit 69: Fresenius - Key offerings
- Exhibit 70: JW Life Science overview
- Exhibit 71: JW Life Science - Business segments
- Exhibit 72: JW Life Science - Organizational developments
- Exhibit 73: JW Life Science - Geographic focus
- Exhibit 74: JW Life Science - Segment focus
- Exhibit 75: JW Life Science - Key offerings
- Exhibit 76: Pfizer overview
- Exhibit 77: Pfizer - Business segments
- Exhibit 78: Pfizer - Organizational developments
- Exhibit 79: Pfizer - Geographic focus
- Exhibit 80: Pfizer - Segment focus
- Exhibit 81: Pfizer - Key offerings
- Exhibit 82: Sippex IV bag overview
- Exhibit 83: Sippex IV bag - Business segments
- Exhibit 84: Sippex IV bag - Organizational developments
- Exhibit 85: Sippex IV bag - Geographic focus
- Exhibit 86: Sippex IV bag - Segment focus
- Exhibit 87: Sippex IV bag - Key offerings

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る